GRETCHEN BALDWIN: Open Payments
NPI 1679817266 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,256 in 53 payments from 18 companies in 2025. Trend: 2023 $348 · 2024 $626 · 2025 $1,256
Food & beverage: $1,256
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $212 |
| ABBVIE INC. | 8 | $186 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $165 |
| Sumitomo Pharma America, Inc. | 6 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $106 |
| Lilly USA, LLC | 4 | $73 |
| GlaxoSmithKline, LLC. | 4 | $64 |
| PFIZER INC. | 3 | $61 |
| Medtronic, Inc. | 1 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
Products named: Kerendia, FARXIGA, VRAYLAR, GEMTESA, CAPLYTA, TRELEGY ELLIPTA, UBRELVY, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
